6
Views
15
CrossRef citations to date
0
Altmetric
Original Article

Thromboembolism During Estrogen Therapy of Prostatic Cancer: Report on Two Cases

&
Pages 108-110 | Received 27 Aug 1970, Published online: 09 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Rafal Turo, Michal Smolski, Rachel Esler, Magda L. Kujawa, Stephen J. Bromage, Neil Oakley, Adebanji Adeyoju, Stephen C. W. Brown, Richard Brough, Andrew Sinclair & Gerald N. Collins. (2014) Diethylstilboestrol for the treatment of prostate cancer: past, present and future. Scandinavian Journal of Urology 48:1, pages 4-14.
Read now
Matti Kontturi. (1991) Metabolic Side-Effects of Estrogen Therapy for Prostatic Cancer. Scandinavian Journal of Urology and Nephrology 25:sup138, pages 127-130.
Read now
Eero A. Sotaniemi & Matti J. Kontturi. (1975) Serum Lipid Levels and Thromboembolic Complications During Estrogen Therapy of Prostatic Cancer. Scandinavian Journal of Urology and Nephrology 9:2, pages 89-93.
Read now
M. Kontturi, E. Sotaniemi & J. Ahlqvist. (1972) Liver Damage and Estrogen Therapy of Prostatic Cancer: Case Report. Scandinavian Journal of Urology and Nephrology 6:3, pages 289-294.
Read now

Articles from other publishers (11)

S.Bruce Malkowicz. (2001) The role of diethylstilbestrol in the treatment of prostate cancer. Urology 58:2, pages 108-113.
Crossref
Allen D. Seftel, J. Patrick Spirnak & Martin I. Resnick. (1989) Hormonal Therapy for Advanced Prostatic Carcinoma. Journal of Surgical Oncology 42:S1, pages 14-20.
Crossref
Roberta J. Lammers & Colin M. Bloor. 1988. Pulmonary Pathology. Pulmonary Pathology 671 690 .
F. Faccioli. (2018) Complicanze Precoci Del Trattamento Del Carcinoma Prostatico Con Des-Difosfato. Urologia Journal 51:1, pages 132-135.
Crossref
H.R. Büller, T.A. Boon, C.P. Henny, N.F. Dabhoiwala & J.W. ten Cate. (1982) Estrogen-Induced Deficiency and Decrease in Antithrombin III Activity in Patients with Prostatic Cancer. Journal of Urology 128:1, pages 72-74.
Crossref
H. FrohmüllerU. Seppelt, H. Bertermann, R. Schmalz & D. Hosenfeld. 1981. Verhandlungsbericht der Deutschen Gesellschaft für Urologie. Verhandlungsbericht der Deutschen Gesellschaft für Urologie 439 442 .
S. Lee GuiceIIIIII, James F. Glenn & David F. Paulson. (1978) Liver and prostate adenocarcinoma: An “estrogen-free” environment?. Urology 11:2, pages 175-178.
Crossref
U. S. Seal, R. P. Doe, D. P. Byar & D. K. Corle. (1976) Response of plasma fibrinogen and plasminogen to hormone treatment and the relation of pretreatment values to mortality in patients with prostatic cancer. Cancer 38:3, pages 1108-1117.
Crossref
U. S. Seal, R. P. Doe, D. P. Byar & D. K. Corle. (1976) Response of serum cholesterol and triglycerides to hormone treatment and the relation of pretreatment values to mortality in patients with prostatic cancer. Cancer 38:3, pages 1095-1107.
Crossref
Matti J. Kontturi & Eero A. Sotaniemi. (1975) Prevention of Body Fluid Retention by Furosemide During Estrogen Therapy of Prostatic Cancer. Journal of Urology 114:2, pages 251-253.
Crossref
Matti J. Kontturi, Eero A. Sotaniemi & Teuvo K.I. Larmi. (1974) Body Fluid and Electrolyte Balance During Estrogen Therapy of Prostatic Cancer. Journal of Urology 111:5, pages 652-655.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.